EMDR vs Supportive Therapy in Relapse Prevention in Traumatized Bipolar Patients
Single-blind, Randomized Controlled Comparison of EMDR Versus Supportive Therapy in Affective Relapse Prevention in Bipolar Patients With a History of Trauma
1 other identifier
interventional
82
1 country
1
Brief Summary
The purpose of this study is to determine whether EMDR (vs supportive therapy) is effective in relapse prevention over an observational period of 2 years in bipolar patients with a history of traumatic events.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 3, 2015
CompletedFirst Posted
Study publicly available on registry
December 18, 2015
CompletedStudy Start
First participant enrolled
March 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2022
CompletedDecember 2, 2022
December 1, 2022
6 years
December 3, 2015
December 1, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of depressive, hypomanic, manic or mixed episodes
Affective relapses are defined as: Depressive relapse: score\>18 in the BDRS, and a score\>3 in the CGI-BP-M, depressive subscale. Hypomanic relapse: a YMRS score between 7 and 20, and a score of 3 or 4 in the CGI-BP-M, the manic subscale. Manic relapse: a YMRS score of \>20, and the CGI-BP-M, the manic subscale, score\>4. Mixed relapse: a BDRS score\>10 in the mixed subscale (max. 15), and a score \>4 in the CGI-BP-M, depressive and manic subscales.
Change of relapses from baseline to visits at 6, 12 and 24 months
Secondary Outcomes (7)
Depressive symptoms
Change from baseline in depressive symptoms at 3, 6, 12 and 24 months
(Hypo)manic symptoms
Change from baseline in (hypo)manic symptoms at 3, 6, 12 and 24 months
Mixed symptoms
Change from baseline in mixed symptoms at 3, 6, 12 and 24 months
Trauma associated symptoms
Change from baseline in trauma symptoms at 3, 6, 12 and 24 months
Functioning
Change from baseline in functioning at 3, 6, 12 and 24 months
- +2 more secondary outcomes
Study Arms (2)
EMDR Therapy
EXPERIMENTALEMDR: 20 individual sessions 60 minutes each for 6 months
Supportive therapy
ACTIVE COMPARATORSupportive therapy: 20 individual sessions 60 minutes each for 6 months.
Interventions
EMDR: We designed a specific EMDR Bipolar Protocol which consists of a detailed interview with respect to traumatic events, the treatment of those with the EMDR standard protocol, and five new specific bipolar adapted EMDR protocols focusing on adherence, insight, de-idealisation of manic symptoms, prodromal symptoms and moodstabilization.
Supportive therapy: Therapists adopt a client-centred focus, meaning that whatever problems the patient presents will be dealt with by providing emotional support and general advise. If no specific topic is mentioned by the patient, information about bipolar disorder and medication will be delivered by the therapist without referring to written or any other material.
Eligibility Criteria
You may qualify if:
- Patients fulfill diagnosis of bipolar I or II disorder, following DSM-IV-RT criteria
- Outpatients
- History of 2 to 6 affective episodes in previous year
- Patients are included in the study 1) in euthymia, defined as Bipolar Depression Rating Scale (BDRS) \<8 and Young Mania Rating Scale (YMRS) \<8 or 2) with subsyndromal symptoms, defined as BDRS ≥8 and \<14 and/or YMRS ≥8 and \<12
- Patients suffered at least from one traumatic event, evaluated by the Distressing Event Scale, Traumatic Life Events Questionnaire, Impact of Event Scale and Subjects Units of Distress.
You may not qualify if:
- Neurological disease
- Currently in a manic phase (YMRS\>18), mixed phase (BDRS≥10 in mixed subscale of BDRS, max.: 15) or depressive phase (BDRS \>18)
- Acute suicidal plans
- Substance Use Disorder within last 3 months (except of nicotine abuse/dependency)
- Trauma focused therapy within last 12 months.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- FIDMAG Germanes Hospitalàrieslead
- Hospital Clinic of Barcelonacollaborator
- Hospital del Marcollaborator
- Hospital Universitari de Bellvitgecollaborator
- Instituto de Salud Carlos IIIcollaborator
- Centro de Investigación Biomédica en Red de Salud Mentalcollaborator
Study Sites (1)
Institut Hospital del Mar d'Investigacions Mèdiques
Barcelona, 08035, Spain
Related Publications (31)
Brackett MA, Salovey P. Measuring emotional intelligence with the Mayer-Salovery-Caruso Emotional Intelligence Test (MSCEIT). Psicothema. 2006;18 Suppl:34-41.
PMID: 17295955BACKGROUNDPino O, Guilera G, Rojo JE, Gomez-Benito J, Bernardo M, Crespo-Facorro B, Cuesta MJ, Franco M, Martinez-Aran A, Segarra N, Tabares-Seisdedos R, Vieta E, Purdon SE, Diez T, Rejas J; Spanish Working Group in Cognitive Function. Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): psychometric properties of a brief scale for cognitive evaluation in schizophrenia. Schizophr Res. 2008 Feb;99(1-3):139-48. doi: 10.1016/j.schres.2007.09.012. Epub 2007 Oct 23.
PMID: 17959358BACKGROUNDPurdo SE: The Screen for Cognitive Impairment in Psychiatry (SCIP): Instructions and three alternate forms. PNLInc, Edmonton, Alberta, 2005.
BACKGROUNDReinares M, Sanchez-Moreno J, Fountoulakis KN. Psychosocial interventions in bipolar disorder: what, for whom, and when. J Affect Disord. 2014 Mar;156:46-55. doi: 10.1016/j.jad.2013.12.017. Epub 2013 Dec 25.
PMID: 24439829BACKGROUNDSimhandl C, Konig B, Amann BL. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients. J Clin Psychiatry. 2014 Mar;75(3):254-62; quiz 263. doi: 10.4088/JCP.13m08601.
PMID: 24717379BACKGROUNDHernandez JM, Cordova MJ, Ruzek J, Reiser R, Gwizdowski IS, Suppes T, Ostacher MJ. Presentation and prevalence of PTSD in a bipolar disorder population: a STEP-BD examination. J Affect Disord. 2013 Sep 5;150(2):450-5. doi: 10.1016/j.jad.2013.04.038. Epub 2013 May 23.
PMID: 23706842BACKGROUNDQuarantini LC, Miranda-Scippa A, Nery-Fernandes F, Andrade-Nascimento M, Galvao-de-Almeida A, Guimaraes JL, Teles CA, Netto LR, Lira SB, de Oliveira IR, Post RM, Kapczinski F, Koenen KC. The impact of comorbid posttraumatic stress disorder on bipolar disorder patients. J Affect Disord. 2010 Jun;123(1-3):71-6. doi: 10.1016/j.jad.2009.08.005. Epub 2009 Sep 3.
PMID: 19732957BACKGROUNDSimhandl C, Radua J, Konig B, Amann BL. The prevalence and effect of life events in 222 bipolar I and II patients: a prospective, naturalistic 4 year follow-up study. J Affect Disord. 2015 Jan 1;170:166-71. doi: 10.1016/j.jad.2014.08.043. Epub 2014 Sep 6.
PMID: 25240845BACKGROUNDMueser KT, Goodman LB, Trumbetta SL, Rosenberg SD, Osher fC, Vidaver R, Auciello P, Foy DW. Trauma and posttraumatic stress disorder in severe mental illness. J Consult Clin Psychol. 1998 Jun;66(3):493-9. doi: 10.1037//0022-006x.66.3.493.
PMID: 9642887BACKGROUNDMcElroy SL. Diagnosing and treating comorbid (complicated) bipolar disorder. J Clin Psychiatry. 2004;65 Suppl 15:35-44.
PMID: 15554795BACKGROUNDShapiro F. Eye movement desensitization: a new treatment for post-traumatic stress disorder. J Behav Ther Exp Psychiatry. 1989 Sep;20(3):211-7. doi: 10.1016/0005-7916(89)90025-6.
PMID: 2576656BACKGROUNDBisson JI, Ehlers A, Matthews R, Pilling S, Richards D, Turner S. Psychological treatments for chronic post-traumatic stress disorder. Systematic review and meta-analysis. Br J Psychiatry. 2007 Feb;190:97-104. doi: 10.1192/bjp.bp.106.021402.
PMID: 17267924BACKGROUNDSeidler GH, Wagner FE. Comparing the efficacy of EMDR and trauma-focused cognitive-behavioral therapy in the treatment of PTSD: a meta-analytic study. Psychol Med. 2006 Nov;36(11):1515-22. doi: 10.1017/S0033291706007963. Epub 2006 Jun 2.
PMID: 16740177BACKGROUNDvan den Berg DP, de Bont PA, van der Vleugel BM, de Roos C, de Jongh A, Van Minnen A, van der Gaag M. Prolonged exposure vs eye movement desensitization and reprocessing vs waiting list for posttraumatic stress disorder in patients with a psychotic disorder: a randomized clinical trial. JAMA Psychiatry. 2015 Mar;72(3):259-67. doi: 10.1001/jamapsychiatry.2014.2637.
PMID: 25607833BACKGROUNDNovo P, Landin-Romero R, Radua J, Vicens V, Fernandez I, Garcia F, Pomarol-Clotet E, McKenna PJ, Shapiro F, Amann BL. Eye movement desensitization and reprocessing therapy in subsyndromal bipolar patients with a history of traumatic events: a randomized, controlled pilot-study. Psychiatry Res. 2014 Sep 30;219(1):122-8. doi: 10.1016/j.psychres.2014.05.012. Epub 2014 May 15.
PMID: 24880581BACKGROUNDAmann BL, Batalla R, Blanch V, Capellades D, Carvajal MJ, Fernández I, García F, Lupo W, Ponte M, Sánchez J, Sanfiz J, Santed A and Luber M: The EMDR Therapy Protocol for Bipolar Disorder. In M. Luber (Ed.), Eye Movement Desensitization and Reprocessing (EMDR) Scripted Protocols and Summary Sheets: Treating trauma, anxiety and mood-related conditions. New York: Springer, 2015 (p 223-287).
BACKGROUNDBerk M, Malhi GS, Cahill C, Carman AC, Hadzi-Pavlovic D, Hawkins MT, Tohen M, Mitchell PB. The Bipolar Depression Rating Scale (BDRS): its development, validation and utility. Bipolar Disord. 2007 Sep;9(6):571-9. doi: 10.1111/j.1399-5618.2007.00536.x.
PMID: 17845271BACKGROUNDSarro S, Madre M, Fernandez-Corcuera P, Valenti M, Goikolea JM, Pomarol-Clotet E, Berk M, Amann BL. Transcultural adaption and validation of the Spanish version of the Bipolar Depression Rating Scale (BDRS-S). J Affect Disord. 2015 Feb 1;172:110-5. doi: 10.1016/j.jad.2014.10.009. Epub 2014 Oct 12.
PMID: 25451403BACKGROUNDYoung RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978 Nov;133:429-35. doi: 10.1192/bjp.133.5.429.
PMID: 728692BACKGROUNDColom F, Vieta E, Martinez-Aran A, Garcia-Garcia M, Reinares M, Torrent C, Goikolea JM, Banus S, Salamero M. [Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale]. Med Clin (Barc). 2002 Sep 28;119(10):366-71. doi: 10.1016/s0025-7753(02)73419-2. Spanish.
PMID: 12372167BACKGROUNDVieta Pascual E, Torrent Font C, Martinez-Aran A, Colom Victoriano F, Reinares Gabnepen M, Benabarre Hernandez A, Comes Forastero M, Goikolea Alberdi JM. [A user-friendly scale for the short and long term outcome of bipolar disorder: the CGI-BP-M]. Actas Esp Psiquiatr. 2002 Sep-Oct;30(5):301-4. Spanish.
PMID: 12372226BACKGROUNDBlake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane TM. The development of a Clinician-Administered PTSD Scale. J Trauma Stress. 1995 Jan;8(1):75-90. doi: 10.1007/BF02105408.
PMID: 7712061BACKGROUNDBobes J, Calcedo-Barba A, Garcia M, Francois M, Rico-Villademoros F, Gonzalez MP, Bascaran MT, Bousono M; Grupo Espanol de Trabajo para el Estudio del Trastornostres Postraumatico. [Evaluation of the psychometric properties of the Spanish version of 5 questionnaires for the evaluation of post-traumatic stress syndrome]. Actas Esp Psiquiatr. 2000 Jul-Aug;28(4):207-18. Spanish.
PMID: 11116791BACKGROUNDWeiss DS, Marmar CR. The Impact of Event Scale - Revised, Assessing Psychological Trauma and PTSD. Guilford Press, New York, 1997 pp.399-411
BACKGROUNDKubany ES, Leisen MB, Kaplan AS, Kelly MP. Validation of a brief measure of posttraumatic stress disorder: the Distressing Event Questionnaire (DEQ). Psychol Assess. 2000 Jun;12(2):197-209. doi: 10.1037//1040-3590.12.2.197.
PMID: 10887766BACKGROUNDKubany ES, Haynes SN, Leisen MB, Owens JA, Kaplan AS, Watson SB, Burns K. Development and preliminary validation of a brief broad-spectrum measure of trauma exposure: the Traumatic Life Events Questionnaire. Psychol Assess. 2000 Jun;12(2):210-24. doi: 10.1037//1040-3590.12.2.210.
PMID: 10887767BACKGROUNDRosa AR, Sanchez-Moreno J, Martinez-Aran A, Salamero M, Torrent C, Reinares M, Comes M, Colom F, Van Riel W, Ayuso-Mateos JL, Kapczinski F, Vieta E. Validity and reliability of the Functioning Assessment Short Test (FAST) in bipolar disorder. Clin Pract Epidemiol Ment Health. 2007 Jun 7;3:5. doi: 10.1186/1745-0179-3-5.
PMID: 17555558BACKGROUNDMeyer TD, Hautzinger M. Cognitive behaviour therapy and supportive therapy for bipolar disorders: relapse rates for treatment period and 2-year follow-up. Psychol Med. 2012 Jul;42(7):1429-39. doi: 10.1017/S0033291711002522. Epub 2011 Nov 21.
PMID: 22099722BACKGROUNDChambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol. 1998 Feb;66(1):7-18. doi: 10.1037//0022-006x.66.1.7.
PMID: 9489259BACKGROUNDHogg B, Valiente-Gomez A, Redolar-Ripoll D, Gardoki-Souto I, Fontana-McNally M, Lupo W, Jimenez E, Madre M, Blanco-Presas L, Reinares M, Cortizo R, Masso-Rodriguez A, Castano J, Argila I, Castro-Rodriguez JI, Comes M, Donate M, Herreria E, Macias C, Mur E, Novo P, Rosa AR, Vieta E, Radua J, Padberg F, Perez-Sola V, Moreno-Alcazar A, Amann BL. High incidence of PTSD diagnosis and trauma-related symptoms in a trauma exposed bipolar I and II sample. Front Psychiatry. 2022 Oct 20;13:931374. doi: 10.3389/fpsyt.2022.931374. eCollection 2022.
PMID: 36339849DERIVEDMoreno-Alcazar A, Radua J, Landin-Romero R, Blanco L, Madre M, Reinares M, Comes M, Jimenez E, Crespo JM, Vieta E, Perez V, Novo P, Donate M, Cortizo R, Valiente-Gomez A, Lupo W, McKenna PJ, Pomarol-Clotet E, Amann BL. Eye movement desensitization and reprocessing therapy versus supportive therapy in affective relapse prevention in bipolar patients with a history of trauma: study protocol for a randomized controlled trial. Trials. 2017 Apr 4;18(1):160. doi: 10.1186/s13063-017-1910-y.
PMID: 28376919DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Benedikt L Amann, MD
Institut Hospital del Mar d'Investigacions Mèdiques
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Research fellow
Study Record Dates
First Submitted
December 3, 2015
First Posted
December 18, 2015
Study Start
March 1, 2016
Primary Completion
March 1, 2022
Study Completion
March 1, 2022
Last Updated
December 2, 2022
Record last verified: 2022-12